Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ChemoCentryx Inc (NASDAQ:CCXI)

8.54
Delayed Data
As of 3:59pm ET
 -0.02 / -0.23%
Today’s Change
4.06
Today|||52-Week Range
9.46
+25.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$374.0M

Company Description

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering, developing and commercializing orally-administered therapeutics that target the chemokine and chemoattractant systems in order to treat autoimmune diseases, inflammatory disorders and cancer. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:

Employees

Shareholders

Individual stakeholders48.77%
Other institutional34.51%
Mutual fund holders23.97%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
Susan M. KanayaCFO, Secretary & Head-Investor Relations
Petrus BekkerChief Medical Officer
Israel CharoSenior Vice President-Research
Markus J. CappelTreasurer & Chief Business Officer